To follow up on the observation, that the RAS‐activated organoids were sensitive to all tested HDAC inhibitors and extend the analysis to human cancer, PDOs from gastric cancer were investigated (Fig 6A). The gene discussed is HDAC9; the disease is gastric cancer.